Tags : Negative


Lundbeck Halts P-II Study of Lu AF11167 in Patients with

Shots: The company discontinues P-II proof POC study of Lu AF11167 in patients with schizophrenia, who are experiencing persistent negative symptoms (NCT03793712). The P-II study evaluated two doses of Lu AF11167 vs PBO as monothx. in patients with schizophrenia and persistent prominent negative symptoms The discontinuation is based on the results of a futility interim […]Read More